Why Pfizer Hungers for Deal With AstraZeneca

Pfizer is betting that a huge deal will actually make it a more nimble player. If it succeeds in its pursuit of rival AstraZeneca, it could have the tools in place to focus on strengths and possibly escape a legacy of aging blockbusters.



from WSJ.com: US Business http://ift.tt/1ryGYvC

via IFTTT